ArticleProstate cancer and prostatic diseases2025

Genomic biomarkers of survival in patients with metastatic hormone-sensitive prostate cancer undergoing intensified androgen deprivation therapy.

Georges Gebrael et al.PubMed ↗Publisher ↗

No numbers read from the abstract.